Psychedelic microdosing has exploded in popularity in recent years, with a noticeable uptick during the COVID-19 pandemic. Research is exploring the possible mental health effects of microdosing. Read some thoughts from Psychedelics Today CEO Joe Moore on microdosing in this article from PsychCentral. Click here to read more.

The post PsychCentral – Microdosing Psychedelics Linked to Lower Anxiety, Depression, Stress appeared first on Psychedelics Today.

Previous articleatai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update
Next articleHealthline – Mental Health Breakthrough: The Therapeutic Benefits of Psychedelics